drugset / Trial / NCT02909166
Role of ALiskiren, a Direct Renin Inhibitor, in Preventing Atrial Fibrillation in Patients With a Pacemaker; RALF.
RandomizedCrossoverQuadruple-blindTreatment
Summary
The aim of the study is to find out whether aliskiren reduces atrial fibrillation burden measured with a pacemaker device
Timeline
- Start
- 2012-01
- Primary completion
- 2016-12
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aliskiren | Small molecule | — | — |